This document provides guidance on performing a pelvic examination. It discusses preparing the patient, examining external genitalia, performing a speculum exam of the vagina and cervix, a bimanual exam of the uterus and adnexa, and a rectal exam. The normal anatomy and findings are outlined, as well as abnormal findings to watch for including infections, masses, cysts, and other abnormalities. The goal of the exam is to thoroughly inspect the pelvic organs and surrounding structures for any signs of pathology or abnormalities.
A vaginal examination (VE) is an extremely intimate examination which is performed regularly and accepted as a routine procedure by midwives during labour. 1,2 A VE can be performed digitally, or by using instruments such as a speculum.
A vaginal examination (VE) is an extremely intimate examination which is performed regularly and accepted as a routine procedure by midwives during labour. 1,2 A VE can be performed digitally, or by using instruments such as a speculum.
nurses/doctor will insert two lubricated, gloved fingers into your vagina with one hand, while the other hand presses gently on the outside of your lower abdomen. During this part of the exam, your doctor will check the size and shape of your uterus and ovaries, noting any tender areas or unusual growths.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
More Related Content
Similar to PELVIC EXAMINATION_retract clitoral hood.pptx
nurses/doctor will insert two lubricated, gloved fingers into your vagina with one hand, while the other hand presses gently on the outside of your lower abdomen. During this part of the exam, your doctor will check the size and shape of your uterus and ovaries, noting any tender areas or unusual growths.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
PELVIC EXAMINATION_retract clitoral hood.pptx
1. PELVICEXAMINATION
DR. L. GIRIJA. M.D. (Hom.),
Associate professor,
DEPARTMENT OF GYNAECOLOGY
AND OBSTETRICS,
SARADA KRISHNA
HOMOEOPATHIC MEDICAL
COLLEGE,
KULASEKHARAM
6. 1. Preparation of the patient:
A. Instruments for pelvic
examination:
1. examining gloves
2. bivalve speculum (plastic or metal)
(various sizes)
3. sponge forceps
4. cotton balls
5. wooden spatula
6. Cyto brush
7. 2 glass slides or whatever your clinic
uses
8. fixative, liquid or spray
5/22/2023
DR.L.GIRIJA SKHMC
7. Use firm pressure, not a light tickling touch
◦ Talk to the patient and tell her what you are doing.
◦ Look at the patient when you ask her a question, if you
can.
◦ But, maintain eye contact and stay in touch with the
patient’s response.
◦ Be sensitive
◦ The patient must have an empty bladder
8. Inspection of ext.genitalia
Vaginal examination
-Inspection of Cx,& vaginal walls
- Palpation of vagina & vaginal Cx
by digital examination
-Bimanual examination of pelvic
organs
Rectal examination
Recto-vaginal examination
5/22/2023
DR.L.GIRIJA SKHMC
10. H.Vestibule
I.Bartholin’s glands (greater vestibular)
J.Skene’s glands (Para urethral) -
K.Lesions, discharge
L. Pubic hair pattern
ANY ANATOMICALABNORMALITIES,
ANY PALPABLE PATHOLOGY OVER THE
AREA
11. Bartholin’s glands and Skene’s glands are
normally non-palpable; swelling and
tenderness indicate abnormality (e.g.,
abscess)
Test for relaxation of supporting
structures:
◦ Palpate perineal tone.
◦ Patient is told to hold breath and strain ;
involuntary loss of urine; or descent of vaginal
wall, or cervix to the introits indicates
abnormality. Inquire about loses of urine with
cough or sneeze.
5/22/2023
DR.L.GIRIJA SKHMC
12. Position the patient at the very edge of the
exam table, with her feet in stirrups, knees
bent and relaxed out to the side
Use a bright light to visually inspect the vulva,
vagina and cervix.
Separate the labia with your gloved fingers to
look for any surface lesions, redness, or
swellings
Look within the pubic hair for the tiny
movement of pubic lice or nits.
Look on the labia for the cauliflower-like
bumps that are known as venereal warts.
5/22/2023
DR.L.GIRIJA SKHMC
13. Look between the folds of skin for ulcerative lesions
that can indicate an active herpes infection.
Gently retract the clitoral hood back, exposing the
clitoris while looking for
peri-clitoral lesions.
Look for the hymen or remnants of the hymen and
identify any redness just exterior to the hymen that
can indicate vulvar vestibulitis.
The periurethral glands (Skene's glands) have tiny
ducts that open onto the surface. Look for them next
to the urethra.
While looking at the urethra, note any discharge
coming from the urethral opening that might
suggest gonorrhea or chlamydia.
5/22/2023
DR.L.GIRIJA SKHMC
16. a) Mon Pubis - observe pubic
hair distribution
b) Labia Majora/Minora -
observe for inflammation,
ulceration, swelling or
nodules
c)Clitoris - observe for
masculinization
2cms)
d)Urethral Orifice - observe for
prolapse
e)Introitus - observe for
inflammation,
ulcerations, nodules previous
episiotomy scar, hymenal
status
5/22/2023
DR.L.GIRIJA SKHMC
Inspect the following structures:
17. Ask the patient to strain (like defecation)
and/or cough
Observe for signs of stress
incontinence and/or abnormal bulging
of anterior and/or posterior walls of
vagina
Abnormal finding include
◦ a) Urethrocele
◦ b) Cystocele
◦ c) Rectocele
◦ d) Enterocele
19. The Handle
The Bills
Thumb Lever
Thumb Nut
5/22/2023
DR.L.GIRIJA SKHMC
20. a) Warm with water (do not use lubricant since it will
interfere with PAP smear)
b) Touch inner thigh with speculum and ask patient if
it is too warm or too cold
c) Ask patient to spread knees laterally to relax
perineal musculature
d) Press fingers on perineal body and assess
relaxation
e) Make sure blades are closed and thumbscrew
loosened
f) Gently insert index finger and assess location of
cervix (anterior vs. posterior)
(1) anteverted uterus = posterior cervix
(2) retroverted uterus = anterior cervix
5/22/2023
DR.L.GIRIJA SKHMC
21. g) Insert gently at 45-degree angle (pointing
towards sacrum)
(1) avoid pinching vulva/introitus
(2) avoid sensitive urethra and anterior vaginal
wall
h) Gently open speculum and attempt to
visualize cervix
(1) if not visualized, assess speculum location by
looking for anterior vaginal wall (rugated)
(2) if rugations seen, close speculum and insert more
posteriorly (cervix will usually “pop” into view)
i) Once cervix visualized, open blades
more and stabilize by tightening
thumbscrew
5/22/2023
DR.L.GIRIJA SKHMC
22. a) Observe position, prolapse, location of transformation
zone, type of cervical os (multiparous vs.
nulliparous), ulcers, color, polyps, plaques, contact
bleeding, abnormal discharge, or bleeding from
cervical os, cysts and nodules
b) Abnormal findings include:
(1) Ectropion
(2) Nabothian cysts
(3) Pelvic inflammatory disease (purulent discharge)
(4) Cervicitis
(5) Herpetic cervicitis
(6) Cervical polyp
(7) Previous obstetrical lacerations
(8) Cervical carcinoma
(9) Cervical prolapse
(10) Chadwick’s sign ( bluish tint
(11) Spontaneous miscarriage
5/22/2023
DR.L.GIRIJA SKHMC
23.
24. 5/22/2023 DR.L.GIRIJA SKHMC
Perform PAP smear:
a) Take three separate specimens and place on three
separate slides (attempt to minimize
contamination from mucous and/or blood)
(1) Cervical scrape: use spatula and scrape
transformation zone in rotary fashion
(2) Endocervical swab/brush: insert into endocervical
canal, rotate and remove
(3) Vaginal pool: collect cells from posterior fornix
with swab
b) Apply fixative to slide immediately
c) If abnormal vaginal discharge present, take swab of
fluid in order to perform a wet mount for viewing
under microscope
26. Must use Dacron Q tip and turn in os and
leave in os at least 20 seconds.
Wet mounts
Obtain cultures for GC/clamydia (Gynprobe)
◦ Trichamonas = Saline
◦ Yeast, Bacterial Vaginosis + - KOH
◦ Determine pH with Nitrazine or pH paper (normal
is 4.5 and below)
◦ “Whiff” test for amine odor characteristic of
Bacterial Vaginosis
5/22/2023
DR.L.GIRIJA SKHMC
27. a) Loosen thumbscrew but keep speculum partially
open during withdraw in order to inspect vaginal
mucosa
b) Inspect for color, degrees of rugations (transverse
ridges), plagues, malodorous discharge,
strawberry spots, white patches, cysts, ulcers,
nodules and fistulae
5/22/2023
DR.L.GIRIJA SKHMC
33. Announce what you are going to do and
then touch the patient on the thigh with
the back of your hand before proceeding.
Insert your index and middle fingers.
Avoid contact with the anterior
structures.
Place your other hand on the patient's
lower abdomen
5/22/2023
DR.L.GIRIJA SKHMC
34. a) Inguinal area -
appreciate abnormal lymph
adenopathy
◦ b) Labia Majora - appreciate
Bartholin gland (pea size)
◦ c) Perineum/introitus -
appreciate perineal body
thickness and vaginismus
◦ d) Urethra - gently palpate
(“milk”) intra vaginal portion
5/22/2023
DR.L.GIRIJA SKHMC
35. Palpate the upper labia majora for masses
related to hernias extending through the
Canal of Nuck.
Palpate the middle and lower portion of
the labia majora for masses suggesting a
Bartholin Duct Cyst.
5/22/2023
DR.L.GIRIJA SKHMC
37. ◦ a) Lubricate index and middle finger of
dominant gloved hand. Abduct thumb and flex
remaining digits.
◦ b) Insert lubricated fingers into vagina and
note vaginal cyst/masses/plaques.
◦ c) Abnormal findings include:
◦ (1) Cervical displacement by pelvic mass
◦ (2) Cervical motion tenderness
◦ (3) Softening due to pregnancy
◦ (4) Unobserved vaginal pathology
5/22/2023
DR.L.GIRIJA SKHMC
38. determine color, size, shape, consistency
and mobility:
◦ 1. Normal: 2-3 cm in size.
pink, smooth epithelium.
old bilateral scars may be seen.
squamocolumnar junction
◦ 2. Abnormal: ulceration, growths.
eversion of cervical lips
endocervical epithelium may brow out onto vaginal
portion of cervix.
Nabothian cysts are of little clinical importance.
5/22/2023
DR.L.GIRIJA SKHMC
39. Palpate the cervix with your index finger
noting size, shape, and consistency.
Gently move the cervix side to side
between your fingers and note mobility
and tenderness.
Gently lift the cervix forward and note
mobility and tenderness.
5/22/2023
DR.L.GIRIJA SKHMC
40. ◦ Five important characteristics of the uterus:
a. Size (large or small)
b. Shape (irregular contour, enlarged, nodular)
c. Position (normal: uterus is at right angles to long axis
of vagina; variations: retroflex, retroverted, ).
5/22/2023
DR.L.GIRIJA SKHMC
41. ◦ Separate the labia minora
◦ Insert the fingers of one hand
into the vagina; depress the
perineum to get more room.
a)Press external hand gently on the
lower abdomen (on the anterior
of the fundus) and with the
finger on either side of the
cervix, attempt to outline the
uterus
5/22/2023
DR.L.GIRIJA SKHMC
42. (1) Size - should be about the size of a small orange
or baseball.
(2) Position - anteverted (80%)
(a) anteflexed
(b) midaxial
(c) retroverted (20%)
(d) retroflexed
(3) Contours - smooth and regular/small AP
diameter
(4) Consistency - firm
(5) Mobility - mobile in all places
(6) Tenderness - essentially non-tende
(7) Cul-de-sac - no masses behind uterus
5/22/2023
DR.L.GIRIJA SKHMC
45. a) Move abdominal wall laterally and move
vaginal fingers into lateral fornices. Attempt
to entrap adnexal structures between
fingertip. Repeat contra lateral side.
b) Note the following normal findings:
c) Abnormal findings include:
a) Change gloves and place lubricated middle
finger in rectum and index finger in vagina.
Sweep from side to side and use abdominal
hand to bring uterus and adnexa towards
vaginorectal hand.
b) Evaluate:
3. Palpate Adnexa via bimanual exam
5/22/2023
DR.L.GIRIJA SKHMC
46. (1) rectal CA
(2) Recto vaginal fistula - weak septum,
express stool through vagina
(3) fundal/posterior fibroids
(4) cul-de-sac mass
5/22/2023
DR.L.GIRIJA SKHMC
47. ◦ (1) Pregnancy - enlarged, soft, globular
◦ (a) 8-week size: large orange
◦ (b) 10-week size: at symphysis
◦ (c) 20-week size: at umbilicus
◦ (2) Fibroids - enlarged, irregular firm
contours
◦ (3) Extreme retroversion
◦ (a) unable to palpate with abdominal hand,
instead fundus palpated in cul-de-sac
◦ (b) significant tenderness
5/22/2023
DR.L.GIRIJA SKHMC
49. Replace the drape and assist the patient to
remove her feet from the stirrups and sit up.
Reassure the patient, if the exam is normal,
say so.
Leave the room and allow the patient to dress
before continuing with the consultation
5/22/2023
DR.L.GIRIJA SKHMC
50. External Genitalia Inspe
ct
Palpat
e
Chart
Hair distribution X Pattern, amount
Labia Majora X
-Symmetry
-Shape
-Color
-Surface
characteristics
X
X
X
X X
Stage of
development,
abnormal
symmetry, color,
surface lesions
Labia Minor X
-Symmetry
-Shape
-Color
-Surface
characteristics
X
X X
Same as labia
majora
5/22/2023
DR.L.GIRIJA SKHMC
51. External Genitalia Inspe
ct
Palpa
te
Chart
Prepuce X Abnormalities
Clitoris X Abnormalities in
size
Urethra & Meatus X X -discharge,
redness
Skenes
(paraurethral)
X X -discharge,
enlargement
Vaginal Orifice
(introitus)
X X Size--closed,
gaping
Bartholins (greater
vestibular)
X X Enlargement,
tenderness
5/22/2023
DR.L.GIRIJA SKHMC
52. External Genitalia Inspe
ct
Palpa
te
Chart
Cystocele X Preset/absent;
degree
Rectocele X Preset/absent;
degree
Uterine Dycensus X Preset/absent;
degree
Perineal Body X X Tone
Anus X -hemmorhoids;
tone, occult
bloodtest
5/22/2023
DR.L.GIRIJA SKHMC
53. Speculus Exam Insp
ect
Palp
ate
Chart
Vaginal
Mucosa
X Color, lesions, rugation
Cervix
-Size
-Shape
-Color
-Symmetry
-Surface
characteristic
s
X
X
X
X
X
X
Size, shape, color, color, symmetry, surface characteristics
Eternal Os X Eversion, erosion, color consistency, odor
GC/clamydia/c
ulture/wet
mount
X Done/not done & why
PAP smear Done/not done & why
5/22/2023
DR.L.GIRIJA SKHMC
55. Bimanual
Exam
Insp
ect
Palp
ate
Chart
Uterus X
-Size X Small or
weeks
gestation
-Shape X Smooth/irreg
ular
-Position X Anteverted/fle
xed, mid,
retrovrted/fle
xed
-Consistency X Soft/firm
-Mobility X Mobile/immo
bile
-Tenderness X Tender/nonte
nder
Andenexa X
-Tubes,
Ovaries,
Ligaments
X Enlargement,
masses,
tenderness
5/22/2023
DR.L.GIRIJA SKHMC